January 8, 2020
Xiromed LLC Launches Commercial Operations
Xiromed LLC, a New Jersey-based generic pharmaceutical company, has launched commercial operations in the United States. With a comprehensive portfolio of generic pharmaceutical products, Xiromed is committed to providing high quality generics to patients in the US market. Beyond the current portfolio of commercial products already launched, Xiromed has a robust development portfolio of generic pharmaceutical products in various stages of development, including injectable, inhalation and complex generic products. Xiromed LLC is the US generic division of Insud Pharma, S.L., a global pharmaceutical company headquartered in Madrid, Spain. Learn more at http://www.xiromed.com/usa/